STEVIE GEESAMAN: Open Payments
NPI 1598425969 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,635 in 182 payments from 21 companies in 2025. Trend: 2023 $1,424 · 2024 $3,688 · 2025 $6,635
Food & beverage: $4,035Speaker / faculty: $2,500Education: $95Travel & lodging: $6
| Company | Payments | Amount |
|---|---|---|
| Verrica Pharmaceuticals Inc. | 7 | $2,678 |
| Arcutis Biotherapeutics, Inc. | 45 | $1,022 |
| Galderma Laboratories, L.P. | 21 | $662 |
| ABBVIE INC. | 22 | $413 |
| GENZYME CORPORATION | 13 | $292 |
| Amgen Inc. | 9 | $255 |
| Botanix SB Inc | 9 | $221 |
| Organon LLC | 12 | $215 |
| Regeneron Healthcare Solutions, Inc. | 8 | $193 |
| Janssen Biotech, Inc. | 11 | $180 |
Products named: YCANTH, Zoryve, NEMLUVIO, DUPIXENT, SOFDRA, RINVOQ, VTAMA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
